SFA
CORT icon

Sequoia Financial Advisors’s Corcept Therapeutics CORT Stock Holding History

Sequoia Financial Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$645K Buy
+7,423
New +$448K ﹤0.01% 1167
2026
Q1 		– Sell
-6,904
Closed -$240K – 1963
2025
Q4 		$240K Buy
6,904
+247
+4% +$19.4K ﹤0.01% 1698
2025
Q3 		$553K Buy
6,657
+3,007
+82% +$218K ﹤0.01% 1079
2025
Q2 		$268K Buy
3,650
+288
+9% +$20.9K ﹤0.01% 1320
2025
Q1 		$384K Buy
+3,362
New +$205K ﹤0.01% 966

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sequoia Financial Advisors's CORT Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 7,423 shares worth $645K. The stake represents ﹤0.01% of the portfolio and ranks #1167 among its holdings. This is a return to the name: Sequoia Financial Advisors previously reported a position in CORT as recently as Q4 2025.

Sequoia Financial Advisors first reported a position in CORT in Q1 2025 and has held it in 5 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Sequoia Financial Advisors held 7,423 shares of Corcept Therapeutics worth $645K as of Q2 2026.
  • Corcept Therapeutics was a new Sequoia Financial Advisors position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1167 holding.
  • Sequoia Financial Advisors first reported a position in Corcept Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.